| Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants JK Hicks, JJ Swen, CF Thorn, K Sangkuhl, ED Kharasch, VL Ellingrod, ... Clinical Pharmacology & Therapeutics 93 (5), 402-408, 2013 | 373 | 2013 |
| Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake … JK Hicks, JR Bishop, K Sangkuhl, DJ Müller, Y Ji, SG Leckband, ... Clinical Pharmacology & Therapeutics 98 (2), 127-134, 2015 | 333 | 2015 |
| Molecular mechanisms of schizophrenia UE Lang, I Puls, DJ Müller, N Strutz-Seebohm, J Gallinat Cellular Physiology and Biochemistry 20 (6), 687-702, 2007 | 316 | 2007 |
| Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3. Pharmacological … SH Kennedy, RW Lam, RS McIntyre, SV Tourjman, V Bhat, P Blier, ... The Canadian Journal of Psychiatry 61 (9), 540-560, 2016 | 231 | 2016 |
| Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process K E Caudle, T E Klein, J M Hoffman, D J Muller, M Whirl-Carrillo, L Gong, ... Current drug metabolism 15 (2), 209-217, 2014 | 222 | 2014 |
| Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications TAP Lett, TJM Wallace, NI Chowdhury, AK Tiwari, JL Kennedy, DJ Müller Molecular Psychiatry 17 (3), 242-266, 2011 | 220 | 2011 |
| Association between a functional polymorphism in the monoamine oxidase A gene promoter and major depressive disorder TG Schulze, DJ Müller, H Krauss, H Scherk, S Ohlraun, YV Syagailo, ... American Journal of Medical Genetics 96 (6), 801-803, 2000 | 201 | 2000 |
| Comprehensive allelotype and genetic analysis of 466 human nervous system tumors A von Deimling, R Fimmers, MC Schmidt, B Bender, F Fassbender, ... Journal of Neuropathology & Experimental Neurology 59 (6), 544-558, 2000 | 191 | 2000 |
| Clinical Pharmacogenetics Implementation Consortium guidelines for HLA‐B genotype and carbamazepine dosing SG Leckband, JR Kelsoe, HM Dunnenberger, AL George, E Tran, ... Clinical Pharmacology & Therapeutics 94 (3), 324-328, 2013 | 183 | 2013 |
| Evidence of association between smoking and alpha7 nicotinic receptor subunit gene in schizophrenia patients. V De Luca, AHC Wong, DJ Muller, GW Wong, RF Tyndale, JL Kennedy Neuropsychopharmacology 29 (8), 1522-1526, 2004 | 166 | 2004 |
| A genome screen for genes predisposing to bipolar affective disorder detects a new susceptibility locus on 8q S Cichon, J Schumacher, DJ Müller, M Hürter, C Windemuth, K Strauch, ... Human Molecular Genetics 10 (25), 2933-2944, 2001 | 163 | 2001 |
| Genetics of antipsychotic treatment emergent weight gain in schizophrenia DJ Müller, JL Kennedy Pharmacogenomics 7 (6), 863-887, 2006 | 156 | 2006 |
| Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug–induced weight gain AK Malhotra, CU Correll, NI Chowdhury, DJ Müller, PK Gregersen, ... Archives of general psychiatry 69 (9), 904-912, 2012 | 152 | 2012 |
| Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis V De Luca, DJ Mueller, A de Bartolomeis, JL Kennedy International Journal of Neuropsychopharmacology 10 (5), 697-704, 2007 | 133 | 2007 |
| Evidence for a novel tumor suppressor gene on chromosome 15 associated with progression to a metastatic stage in breast cancer. W Wick, I Petersen, RK Schmutzler, B Wolfarth, D Lenartz, E Bierhoff, ... Oncogene 12 (5), 973-978, 1996 | 132 | 1996 |
| Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update JK Hicks, K Sangkuhl, JJ Swen, VL Ellingrod, DJ Müller, K Shimoda, ... Clinical Pharmacology & Therapeutics 102 (1), 37-44, 2017 | 127 | 2017 |
| Brain-derived neurotrophic factor (BDNF) gene and rapid-cycling bipolar disorder Family-based association study DJ Müller, V De Luca, T Sicard, N King, J Strauss, JL Kennedy The British Journal of Psychiatry 189 (4), 317-323, 2006 | 126 | 2006 |
| Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1). F Grünhage, TG Schulze, DJ Müller, M Lanczik, E Franzek, M Albus, ... Molecular Psychiatry 5 (3), 275-282, 2000 | 112 | 2000 |
| The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia. DJ Müller, TA Klempan, V De Luca, T Sicard, J Volavka, P Czobor, ... Neuroscience Letters 379 (2), 81-89, 2005 | 111 | 2005 |
| Association study of 12 polymorphisms spanning the dopamine D2 receptor gene and clozapine treatment response in two treatment refractory/intolerant populations R Hwang, T Shinkai, V De Luca, DJ Müller, X Ni, F Macciardi, S Potkin, ... Psychopharmacology 181 (1), 179-187, 2005 | 110 | 2005 |
Arun Kumar TiwariCentre for Addiction and Mental Health, TorontoVerified email at camh.ca
